Market revenue in 2022 | USD 1,487.8 million |
Market revenue in 2030 | USD 2,373.0 million |
Growth rate | 6% (CAGR from 2022 to 2030) |
Largest segment | Oxygen source equipment |
Fastest growing segment | Oxygen Delivery Devices |
Historical data | 2018 - 2021 |
Base year | 2022 |
Forecast period | 2023 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Oxygen Source Equipment, Oxygen Delivery Devices |
Key market players worldwide | GE HealthCare Technologies Inc Common Stock, Inogen Inc, Smiths Group PLC, Fisher & Paykel Healthcare Corp Ltd, Koninklijke Philips NV, Allied Healthcare Products Inc, Teleflex Inc, Chart Industries Inc, Draegerwerk AG & Co KGaA, Niterra Co Ltd, Invacare, Hersill, DeVilbiss Healthcare, Tecno-Gaz |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to oxygen therapy market will help companies and investors design strategic landscapes.
Oxygen source equipment was the largest segment with a revenue share of 71.86% in 2022. Horizon Databook has segmented the UK oxygen therapy market based on oxygen source equipment, oxygen delivery devices covering the revenue growth of each sub-segment from 2018 to 2030.
The UK oxygen therapy market accounted for the second-largest revenue share of 27.93% during the forecast period. High incidence of respiratory diseases, which have affected one in five individuals in the UK, is expected to fuel market growth in this country.
In England, these respiratory diseases are the thirdleading cause of death after cardiovascular diseases and cancer. Pneumonia, lung cancer, and COPD are the primary causes of death in the UK. In addition, the UK accounted for 84,721 respiratory deaths in 2018.
As per statistics published by Eurostat. Hence, growing government initiatives to regulate and manage respiratory disorders are expected to drive UK oxygen therapy market. Furthermore, the UK primarily consist of small- and medium-sized medical devices companies.
Horizon Databook provides a detailed overview of country-level data and insights on the UK oxygen therapy market , including forecasts for subscribers. This country databook contains high-level insights into UK oxygen therapy market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account